Message from the Representative director
Delawave will continue to develop new medical devices and deliver them to the world, thereby contributing to medical care from the aspect of technology.
We value honesty and will continue to take on challenges, despite difficulties, to develop and provide medical devices that are useful to patients and healthcare professionals. We look forward to your continued support for DELAWAVE.
Kenji Taira, Representative Director, Delawave, Inc.
We are a technology-based startup developing medical devices for coronary arteries
Our solution is a coronary imaging catheter and system for CAD treatment.
Introducing Delawave's coronary artery disease (CAD) treatment project
Approved by the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan in March 2021
・Intravascular Optical Coherence Tomography (OCT) catheter
・OCT diagnostic imaging system
Delawave is looking for a highly passionate talent who can make use of the experience they have accumulated and work together with us.
If you have any questions about our company Please contact us using the form below